Isolation of ko157 and genotyping: The ko157 was an embryonic lethal mutant presenting cardia bifida. For meiotic mapping, the ko157 was crossed to TL strain. The ko157 locus was defined by genotyping of ko157 mutant embryos (400 diploid) using SSLP markers on the linkage group 5. We identified single amino acid substitution (R153S) in Spns2 protein.
Transgenic zebrafish:
We constructed a reporter plasmid DNA pTol-cmlc2P-mRFP with the promoter region of cmlc2 fused to mRFP. We established two transgenic lines cmlc2:mRFP ko07 and cmlc2:mRFP ko08 that stably expressed mRFP in developing myocardial cells. We used both Tg(cmlc2:mRFP) transgenic lines throughout the experiments in the present study.
RNA probes:
Antisense RNA probes labeled with digoxigenin (DIG) for spns2, cmlc2, nkx2.5, fli1, amhc, vmhc, sox17, foxa2, hand2, gata1 and pax2 were prepared by using the RNA labeling kit (Roche). Whole-mount in situ hybridization was performed as previously described (1) .
Measurement of S1P export from the cells:
To examine the S1P export, the CHO cells constitutively expressing mouse sphingosine kinase 1 (mSphk1) were generated (CHO-SphK cells) by using the flp-in system (Invitrogen). Cells were cultured under 5%
CO2 at 37˚C. Expression plasmids (Spns1-EGFP or Spns2-EGFP) were transfected into the CHO-SphK cells (1x10 5 cells) using the Lipofectamine 2000 reagent (Invitrogen). After 6-16 h incubation, medium was changed to F12 medium (Sigma) with 10% fetal bovine serum (FBS) and 10 mM fumonisine B. released in F12 medium with 10% FBS was greater than that with 1% BSA.
Measurement of endogenous S1P by HPLC:
The endogenous S1P released from the cells was measured by the o-phthalaldehyde (OPA) modification followed by HPLC analysis as a modified protocol from Min et al. (2) . Briefly, CHO-SphK cells (4x10 5 cells) were transfected with either EGFP, zSpns2-EGFP or zSpns2-R153S-EGFP expression plasmid.
After 24 h, the medium (F12 medium with 10% FBS) was changed to releasing medium (F12 medium with 1% BSA, 10 mM sodium glycerophosphate, 5 mM sodium fluoride and 1 mM semicarbazide). After 12 h incubation, 100 μl aliquots of the medium were transferred to new tubes and subjected to lipid extraction in alkaline chloroform condition.
C17-S1P (30 pmol) was added to each sample as an internal standard. Extracted S1P was dephosphorylated with calf intestinal alkaline phosphatase (30 units) for 90 min at 37˚C.
The resulting sphingosine was extracted with chloroform, dried and resuspended in ethanol.
OPA modification was performed at room temperature for 1 h. 
